
Silexion Therapeutics (NASDAQ: SLXN)
$0.81
(-4.3%)
-$0.04
Price as of June 17, 2025, 3:46 p.m. ET
Silexion Therapeutics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Silexion Therapeutics Company Info
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.